Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Rigalli, Juan Pablo [VerfasserIn]   i
 Gagliardi, Anna [VerfasserIn]   i
 Diester, Klara [VerfasserIn]   i
 Bajraktari-Sylejmani, Gzona [VerfasserIn]   i
 Blank, Antje [VerfasserIn]   i
 Burhenne, Jürgen [VerfasserIn]   i
 Lenard, Alexander [VerfasserIn]   i
 Werntz, Lars [VerfasserIn]   i
 Huppertz, Andrea [VerfasserIn]   i
 Münch, Lena [VerfasserIn]   i
 Wendt, Janica Margrit [VerfasserIn]   i
 Sauter, Max [VerfasserIn]   i
 Haefeli, Walter E. [VerfasserIn]   i
 Weiß, Johanna [VerfasserIn]   i
Titel:Extracellular vesicles as surrogates for the regulation of the drug transporters ABCC2 (MRP2) and ABCG2 (BCRP)
Verf.angabe:Juan Pablo Rigalli, Anna Gagliardi, Klara Diester, Gzona Bajraktari-Sylejmani, Antje Blank, Jürgen Burhenne, Alexander Lenard, Lars Werntz, Andrea Huppertz, Lena Münch, Janica Margrit Wendt, Max Sauter, Walter Emil Haefeli and Johanna Weiss
E-Jahr:2024
Jahr:8 April 2024
Umfang:18 S.
Fussnoten:Gesehen am 11.09.2024
Titel Quelle:Enthalten in: International journal of molecular sciences
Ort Quelle:Basel : Molecular Diversity Preservation International, 2000
Jahr Quelle:2024
Band/Heft Quelle:25(2024), 7, Artikel-ID 4118, Seite 1-18
ISSN Quelle:1422-0067
 1661-6596
Abstract:Drug efflux transporters of the ATP-binding-cassette superfamily play a major role in the availability and concentration of drugs at their site of action. ABCC2 (MRP2) and ABCG2 (BCRP) are among the most important drug transporters that determine the pharmacokinetics of many drugs and whose overexpression is associated with cancer chemoresistance. ABCC2 and ABCG2 expression is frequently altered during treatment, thus influencing efficacy and toxicity. Currently, there are no routine approaches available to closely monitor transporter expression. Here, we developed and validated a UPLC-MS/MS method to quantify ABCC2 and ABCG2 in extracellular vesicles (EVs) from cell culture and plasma. In this way, an association between ABCC2 protein levels and transporter activity in HepG2 cells treated with rifampicin and hypericin and their derived EVs was observed. Although ABCG2 was detected in MCF7 cell-derived EVs, the transporter levels in the vesicles did not reflect the expression in the cells. An analysis of plasma EVs from healthy volunteers confirmed, for the first time at the protein level, the presence of both transporters in more than half of the samples. Our findings support the potential of analyzing ABC transporters, and especially ABCC2, in EVs to estimate the transporter expression in HepG2 cells.
DOI:doi:10.3390/ijms25074118
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.3390/ijms25074118
 Volltext: https://www.mdpi.com/1422-0067/25/7/4118
 DOI: https://doi.org/10.3390/ijms25074118
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:ABC transporters
 ABCC2
 ABCG2
 chemoresistance
 exosomes
 extracellular vesicles
 multidrug resistance
 pharmacokinetics
K10plus-PPN:1902323823
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69252563   QR-Code
zum Seitenanfang